2023-2024 年俄亥俄州吸毒者对赛拉嗪的认识和态度。

IF 4 2区 社会学 Q1 SUBSTANCE ABUSE Harm Reduction Journal Pub Date : 2024-10-14 DOI:10.1186/s12954-024-01097-5
Nichole L Michaels, Saroj Bista, Ashley Short Mejia, Hannah Hays, Gary A Smith
{"title":"2023-2024 年俄亥俄州吸毒者对赛拉嗪的认识和态度。","authors":"Nichole L Michaels, Saroj Bista, Ashley Short Mejia, Hannah Hays, Gary A Smith","doi":"10.1186/s12954-024-01097-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The prevalence of xylazine, a non-opioid tranquilizer not for human consumption, in illicitly manufactured fentanyl is increasing in the United States. However, little is known about xylazine awareness and attitudes among people who use drugs.</p><p><strong>Methods: </strong>A cross-sectional survey of people who use drugs in Ohio was conducted from November 2023 - May 2024 to identify xylazine awareness and attitudes in rural and urban counties across the state. Study participants were recruited from naloxone distribution sites, including health departments, syringe service programs, and community-based organizations.</p><p><strong>Results: </strong>Among 630 people who use drugs in Ohio, more than one-half (53.5%) were unaware of xylazine being in \"street drugs,\" regardless of urbanicity. Among individuals who were aware of xylazine, most (73.0%) indicated they did not want to use the drug and try to avoid it. In addition, 75.8% of this group felt it was \"very\" or \"extremely\" important to know if xylazine was in their drugs.</p><p><strong>Discussion: </strong>This research found that many people who use drugs in Ohio are unaware of xylazine and its risks. An important finding of this study is that most individuals who had heard of xylazine did not want to use it and were concerned about knowing whether xylazine was in their drugs.</p>","PeriodicalId":12922,"journal":{"name":"Harm Reduction Journal","volume":"21 1","pages":"182"},"PeriodicalIF":4.0000,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11479538/pdf/","citationCount":"0","resultStr":"{\"title\":\"Xylazine awareness and attitudes among people who use drugs in Ohio, 2023-2024.\",\"authors\":\"Nichole L Michaels, Saroj Bista, Ashley Short Mejia, Hannah Hays, Gary A Smith\",\"doi\":\"10.1186/s12954-024-01097-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The prevalence of xylazine, a non-opioid tranquilizer not for human consumption, in illicitly manufactured fentanyl is increasing in the United States. However, little is known about xylazine awareness and attitudes among people who use drugs.</p><p><strong>Methods: </strong>A cross-sectional survey of people who use drugs in Ohio was conducted from November 2023 - May 2024 to identify xylazine awareness and attitudes in rural and urban counties across the state. Study participants were recruited from naloxone distribution sites, including health departments, syringe service programs, and community-based organizations.</p><p><strong>Results: </strong>Among 630 people who use drugs in Ohio, more than one-half (53.5%) were unaware of xylazine being in \\\"street drugs,\\\" regardless of urbanicity. Among individuals who were aware of xylazine, most (73.0%) indicated they did not want to use the drug and try to avoid it. In addition, 75.8% of this group felt it was \\\"very\\\" or \\\"extremely\\\" important to know if xylazine was in their drugs.</p><p><strong>Discussion: </strong>This research found that many people who use drugs in Ohio are unaware of xylazine and its risks. An important finding of this study is that most individuals who had heard of xylazine did not want to use it and were concerned about knowing whether xylazine was in their drugs.</p>\",\"PeriodicalId\":12922,\"journal\":{\"name\":\"Harm Reduction Journal\",\"volume\":\"21 1\",\"pages\":\"182\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2024-10-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11479538/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Harm Reduction Journal\",\"FirstCategoryId\":\"90\",\"ListUrlMain\":\"https://doi.org/10.1186/s12954-024-01097-5\",\"RegionNum\":2,\"RegionCategory\":\"社会学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Harm Reduction Journal","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.1186/s12954-024-01097-5","RegionNum":2,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

摘要

背景:在美国,非法制造的芬太尼中含有非人用的非阿片类镇静剂异丙嗪的情况越来越普遍。然而,人们对使用毒品的人对异丙嗪的认识和态度知之甚少:2023 年 11 月至 2024 年 5 月期间,对俄亥俄州的吸毒者进行了一次横断面调查,以确定该州城乡各县对二甲苯嗪的认识和态度。研究参与者是从纳洛酮发放点招募的,包括卫生部门、注射器服务计划和社区组织:在俄亥俄州的 630 名吸毒者中,超过半数(53.5%)的人不知道 "街头毒品 "中含有二甲苯嗪,无论其城市化程度如何。在知道有异丙嗪的人中,大多数(73.0%)表示他们不想使用这种毒品,并尽量避免使用。此外,75.8% 的人认为了解他们的毒品中是否含有甲苯噻嗪 "非常 "或 "极其 "重要:讨论:这项研究发现,俄亥俄州的许多吸毒者并不了解异丙嗪及其风险。本研究的一个重要发现是,大多数听说过二甲肼的人并不想使用它,他们关心的是了解自己的毒品中是否含有二甲肼。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Xylazine awareness and attitudes among people who use drugs in Ohio, 2023-2024.

Background: The prevalence of xylazine, a non-opioid tranquilizer not for human consumption, in illicitly manufactured fentanyl is increasing in the United States. However, little is known about xylazine awareness and attitudes among people who use drugs.

Methods: A cross-sectional survey of people who use drugs in Ohio was conducted from November 2023 - May 2024 to identify xylazine awareness and attitudes in rural and urban counties across the state. Study participants were recruited from naloxone distribution sites, including health departments, syringe service programs, and community-based organizations.

Results: Among 630 people who use drugs in Ohio, more than one-half (53.5%) were unaware of xylazine being in "street drugs," regardless of urbanicity. Among individuals who were aware of xylazine, most (73.0%) indicated they did not want to use the drug and try to avoid it. In addition, 75.8% of this group felt it was "very" or "extremely" important to know if xylazine was in their drugs.

Discussion: This research found that many people who use drugs in Ohio are unaware of xylazine and its risks. An important finding of this study is that most individuals who had heard of xylazine did not want to use it and were concerned about knowing whether xylazine was in their drugs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Harm Reduction Journal
Harm Reduction Journal Medicine-Public Health, Environmental and Occupational Health
CiteScore
5.90
自引率
9.10%
发文量
126
审稿时长
26 weeks
期刊介绍: Harm Reduction Journal is an Open Access, peer-reviewed, online journal whose focus is on the prevalent patterns of psychoactive drug use, the public policies meant to control them, and the search for effective methods of reducing the adverse medical, public health, and social consequences associated with both drugs and drug policies. We define "harm reduction" as "policies and programs which aim to reduce the health, social, and economic costs of legal and illegal psychoactive drug use without necessarily reducing drug consumption". We are especially interested in studies of the evolving patterns of drug use around the world, their implications for the spread of HIV/AIDS and other blood-borne pathogens.
期刊最新文献
Analysis of different populations accessing online overdose response training and harm reduction supplies (ADORES). How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023. How we understand fully the supply, demand, and harm reduction in drugs policy in Vietnam? Improving hospital care for people who use drugs: deliberative process development of a clinical guideline for opioid withdrawal management. Women, gender and drugs: between research and action.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1